We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNA icon
6026
PUT
Snap-on
SNA
$21.2B
$58K ﹤0.01%
400
-7,000
-95% -$1.11M
DSKE
6027
DELISTED
Daseke, Inc. Common Stock
DSKE
$58K ﹤0.01%
15,753
+2,362
+18% +$12.7K
ACOR
6028
CALL
DELISTED
Acorda Therapeutics
ACOR
$58K ﹤0.01%
31
+17
+121% +$37K
SNDE
6029
DELISTED
Sundance Energy Inc. Common Stock
SNDE
$58K ﹤0.01%
+2,317
New +$111K
WIN
6030
DELISTED
Windstream Holdings Inc
WIN
$58K ﹤0.01%
27,806
+5,076
+22% +$18.9K
AGS
6031
DELISTED
PlayAGS
AGS
$57K ﹤0.01%
2,477
-3,608
-59% -$85.7K
AOSL icon
6032
Alpha and Omega Semiconductor
AOSL
$931M
$57K ﹤0.01%
5,610
+143
+3% +$1.47K
BRW
6033
Saba Capital Income & Opportunities Fund
BRW
$342M
$57K ﹤0.01%
6,405
-1,425
-18% -$13.6K
CRTO icon
6034
Criteo S.A. Ordinary Shares
CRTO
$1.1B
$57K ﹤0.01%
2,500
-5,783
-70% -$130K
CULP icon
6035
Culp Inc
CULP
$44.8M
$57K ﹤0.01%
3,000
-70
-2% -$1.51K
IWL icon
6036
iShares Russell Top 200 ETF
IWL
$2.17B
$57K ﹤0.01%
982
-16
-2% -$1K
KT icon
6037
KT
KT
$8.8B
$57K ﹤0.01%
4,031
+1,581
+65% +$22.9K
OCUL icon
6038
PUT
Ocular Therapeutix
OCUL
$1.85B
$57K ﹤0.01%
14,200
+13,500
+1,929% +$74.4K
RARE icon
6039
PUT
Ultragenyx Pharmaceutical
RARE
$2.56B
$57K ﹤0.01%
1,300
-2,900
-69% -$158K
REET icon
6040
iShares Global REIT ETF
REET
$5.12B
$57K ﹤0.01%
2,423
+1,465
+153% +$36.1K
URG
6041
Ur-Energy
URG
$497M
$57K ﹤0.01%
87,463
-20,000
-19% -$14K
VGIT icon
6042
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
$57K ﹤0.01%
+900
New +$56K
SMMF
6043
DELISTED
Summit Financial Group, Inc.
SMMF
$57K ﹤0.01%
2,942
-72
-2% -$1.51K
ATCO
6044
DELISTED
Atlas Corp.
ATCO
$57K ﹤0.01%
7,197
+4,378
+155% +$38.1K
TCDA
6045
DELISTED
Tricida, Inc. Common Stock
TCDA
$57K ﹤0.01%
2,411
-851
-26% -$24.5K
FLXN
6046
PUT
DELISTED
Flexion Therapeutics, Inc.
FLXN
$57K ﹤0.01%
5,000
+1,500
+43% +$23.5K
RARX
6047
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$57K ﹤0.01%
3,127
+45
+1% +$706
CTSO icon
6048
Cytosorbents Corp
CTSO
$22M
$56K ﹤0.01%
6,950
-1,223
-15% -$12.1K
CWBC
6049
Community West Bancshares
CWBC
$682M
$56K ﹤0.01%
2,941
-224
-7% -$4.45K
IHDG icon
6050
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.23B
$56K ﹤0.01%
2,000

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.